INTERNATIONAL PATENT: REFORGENE MEDICINE, 广州瑞风生物科技有限公司 FILES APPLICATION FOR "DEAMINASE, SINGLE BASE EDITOR AND APPLICATION THEREOF"

GENEVA, Nov. 10 -- REFORGENE MEDICINE (No. 131-150 And No. 231-250 In Building H6, No. 101-120 And No. 201-220 In Building H7, No. 39 Ruihe Road, Huangpu DistrictGuangzhou, Guangdong 510535), 广州瑞风生物科技有限公司 (中国广东省广州市黄埔区瑞和路39号H6栋131-150、H6栋231-250、H7栋101-120、H7栋201-220) filed a patent application (PCT/CN2025/091312) for "DEAMINASE, SINGLE BASE EDITOR, AND APPLICATION THEREOF" on Apr 25, 2025. With publication no. WO/2025/228273, the details related to the patent application was published on Nov 06, 2025.

Nota...